ERROL B DESOUZA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERROL B DESOUZA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERROL B DESOUZA. ERROL B DESOUZA is a Director in CATALYST BIOSCIENCES, INC. ($CBIO) and a CEO in Biodel Inc ($BIOD) and a in Cyclerion Therapeutics, Inc. ($CYCN) and a Director in Royalty Pharma plc ($RPRX).
Companies in which ERROL B DESOUZA is an Insider
ALBIREO PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERROL B DESOUZA: CEO
Holdings: 159,416 shares
Latest Transaction: Oct 02 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CATALYST BIOSCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERROL B DESOUZA: Director
Holdings: 22,807 shares
Current Value: $13,456
Latest Transaction: Apr 05 2021
$CBIO Market Capitalization: $6.51M
$CBIO Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cyclerion Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERROL B DESOUZA:
Holdings: 0 shares
Latest Transaction: Jun 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Royalty Pharma plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERROL B DESOUZA: Director
Holdings: 50,370 shares
Latest Transaction: Jun 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ERROL B DESOUZA
Sentiment: All, ALBO, CBIO, CYCN, RPRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2021 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 5,726 | 0 | 50,370 | 44.6 K to 50.4 K (+12.83 %) |
| Jun 29 2021 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 5,726 | 0 | 50,370 | 44.6 K to 50.4 K (+12.83 %) |
| Jun 28 2021 | CYCN | Cyclerion Therapeu ... | DESOUZA ERROL B | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
| Apr 05 2021 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,926 | 0 | 22,807 | 19.9 K to 22.8 K (+14.72 %) |
| Jan 06 2021 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,129 | 0 | 19,881 | 17.8 K to 19.9 K (+11.99 %) |
| Oct 02 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 3,125 | 0 | 17,752 | 14.6 K to 17.8 K (+21.36 %) |
| Sep 23 2020 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Option Exercise | A | 0.00 | 53,915 | 0 | 53,915 |